)
Edge3 Apr 2026
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
EXACT Therapeutics
EXACT Therapeutics (EXTX) investor relations material
EXACT Therapeutics H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary9 Apr, 2026
Executive summary
Achieved significant progress in advancing PS101 for locally advanced pancreatic cancer, with ENACT Phase 2 trial initiated and first patient treated in June 2025.
Positive final results from ACTIVATE Phase 1 trial in liver metastases, showing 4x greater tumor shrinkage with PS101 plus chemotherapy.
Strengthened strategic partnership with GE HealthCare and secured additional patents.
Maintained a focused strategy on high unmet medical need cancers, especially pancreatic cancer.
Financial highlights
Total operating costs for 2025 were NOK 84.9 million, up from NOK 52.9 million in 2024, reflecting increased R&D activity.
Comprehensive loss for 2025 was NOK -87.0 million, compared to NOK -52.3 million in 2024.
Cash and cash equivalents at year-end 2025 were NOK 24.3 million, down from NOK 100 million at end of 2024.
Equity ratio declined to 46% (from 75% in 2024) due to increased expenses and reduced cash position.
Government grants recognized totaled NOK 7.8 million in 2025.
Outlook and guidance
Focus in 2026 will be on executing the ENACT Phase 2 trial, with interim analysis and patient recruitment completion expected in H2 2026.
Strategic partnership with GE HealthCare to continue, aiming for a commercial-ready ultrasound platform.
Preclinical programs in blood-brain barrier, immuno-oncology, and gene therapy to progress.
Successful warrant exercise in early 2026 raised NOK 59 million, ensuring liquidity for planned activities through 2026 and beyond.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from EXACT Therapeutics
- Strong early clinical results and secured funding support expansion in oncology and beyond.EXTX
Investor update11 Feb 2026 - $13M raised, including $7M from a medtech leader, to fund phase II trial and expand ACT platform.EXTXStatus update6 Feb 2026
- Ultrasound-activated therapy achieved >10x tumor reduction and advances to Phase 2 in pancreatic cancer.EXTXISTU 2024 presentation6 Feb 2026
- ACT delivers >10x tumor shrinkage in liver metastases and advances to Phase 2 pancreatic cancer trials.EXTXCMR Symposium 2024 presentation6 Feb 2026
- PS101 delivers promising early results in pancreatic cancer, with strong clinical and financial momentum.EXTXCompany presentation6 Feb 2026
- ACT technology shows strong clinical promise in oncology, with Phase 2 trials underway.EXTXDNB Carnegie Nordic Healthcare Conference Presentation25 Nov 2025
- ENACT Phase 2 trial launched, ACTIVATE Phase 1 results strong, cash burn rises with clinical progress.EXTXH1 202525 Sep 2025
- Net loss widened as EXACT pivots to pancreatic cancer trials and seeks urgent new funding.EXTXH1 202413 Jun 2025
- NOK 145 million raised and GE HealthCare partnership drive EXACT's 2025 clinical focus.EXTXH2 20249 Jun 2025
Next EXACT Therapeutics earnings date
H1 20263 Sep, 2026
EXACT Therapeutics
Next EXACT Therapeutics earnings date
H1 20263 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage